444 Efficacy analysis of niraparib using patient-derived xenograft of rare subtypes of ovarian cancer | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About

YouTube

Podcasts

Zoom Journal Club
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Translational research biomarkers

444 Efficacy analysis of niraparib using patient-derived xenograft of rare subtypes of ovarian cancer

Free

Online download statistics by month:

Online download statistics by month: October 2021 to April 2024

	Abstract	Full	Pdf
Oct 2021	61	0	15
Nov 2021	48	0	11
Dec 2021	12	0	0
Jan 2022	94	0	5
Feb 2022	18	0	1
Mar 2022	42	0	6
Apr 2022	18	0	3
May 2022	20	0	10
Jun 2022	12	0	4
Jul 2022	24	0	2
Aug 2022	20	0	7
Sep 2022	10	0	6
Oct 2022	16	0	3
Nov 2022	6	0	1
Dec 2022	24	0	6
Jan 2023	19	0	6
Feb 2023	16	0	0
Mar 2023	8	0	0
Apr 2023	4	0	0
May 2023	16	0	0
Jun 2023	6	0	1
Jul 2023	14	0	7
Aug 2023	10	0	4
Sep 2023	6	0	0
Oct 2023	14	0	1
Nov 2023	18	0	1
Dec 2023	27	0	0
Jan 2024	18	0	1
Feb 2024	10	0	1
Mar 2024	10	0	3
Apr 2024	16	0	2
Total	637	0	107